Pharmacokinetics of felodipine in patients with impaired renal function.
Open Access
- 1 January 1989
- journal article
- research article
- Published by Wiley in British Journal of Clinical Pharmacology
- Vol. 27 (1) , 67-74
- https://doi.org/10.1111/j.1365-2125.1989.tb05336.x
Abstract
1. The pharmacokinetics of felodipine and its effects on blood pressure and heart rate were studied in eight male patients aged between 28 and 57 years with a glomerular filtration rate, GFR, between 8 and 68 ml min-1, following single i.v. and oral administration. 2. Clearance, Cmax, AUC, Vss and V, of felodipine were unaffected by the renal disease. The metabolite excretion (14C-labelled) was slower than in healthy subjects. Initial renal clearance of these metabolites correlated with individual GFR values. The total amount of the dose excreted in the urine was also decreased.This publication has 21 references indexed in Scilit:
- Pharmacokinetics and Blood Pressure Effects of Felodipine in Elderly Hypertensive PatientsClinical Pharmacokinetics, 1988
- Calcium entry blockers for systemic hypertensionThe American Journal of Cardiology, 1987
- Clinical Evaluation of Felodipine in Patients with Refractory HypertensionDrugs, 1987
- Metabolism of [14C] Felodipine, a New Vasodilating Drug, in Healthy VolunteersDrugs, 1987
- Calcium antagonism—A New concept for treating essential hypertensionThe American Journal of Cardiology, 1986
- Pharmacokinetic parameter estimates from several least squares procedures: Superiority of extended least squaresJournal of Pharmacokinetics and Biopharmaceutics, 1985
- Acute Diuretic/Natriuretic Properties of Felodipine in ManDrugs, 1985
- Vascular Selectivity of FelodipineDrugs, 1985
- Absorption, Distribution and Elimination of Felodipine in ManDrugs, 1985
- Extended least squares nonlinear regression: A possible solution to the “choice of weights” problem in analysis of individual pharmacokinetic dataJournal of Pharmacokinetics and Biopharmaceutics, 1984